DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 5.741
AS - Asia 3.043
EU - Europa 2.846
SA - Sud America 359
Continente sconosciuto - Info sul continente non disponibili 40
AF - Africa 30
OC - Oceania 5
Totale 12.064
Nazione #
US - Stati Uniti d'America 5.640
SG - Singapore 1.160
CN - Cina 807
IE - Irlanda 576
RU - Federazione Russa 515
TR - Turchia 422
SE - Svezia 351
BR - Brasile 327
DE - Germania 285
HK - Hong Kong 285
IT - Italia 270
GB - Regno Unito 252
UA - Ucraina 225
VN - Vietnam 217
FR - Francia 148
FI - Finlandia 133
CA - Canada 67
IN - India 31
BE - Belgio 29
BD - Bangladesh 23
JP - Giappone 16
MX - Messico 16
AR - Argentina 15
PL - Polonia 15
TW - Taiwan 14
ZA - Sudafrica 13
ES - Italia 12
NL - Olanda 11
IQ - Iraq 10
PK - Pakistan 8
MA - Marocco 7
SA - Arabia Saudita 7
AT - Austria 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
EU - Europa 5
TT - Trinidad e Tobago 5
CZ - Repubblica Ceca 4
AU - Australia 3
ID - Indonesia 3
JM - Giamaica 3
MY - Malesia 3
OM - Oman 3
PS - Palestinian Territory 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
CL - Cile 2
CR - Costa Rica 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 12.029
Città #
Jacksonville 872
Singapore 753
Chandler 685
Dublin 575
San Jose 546
Ashburn 527
Dallas 351
Boardman 291
Hong Kong 278
Santa Clara 251
Izmir 191
Nanjing 186
San Mateo 168
Council Bluffs 163
Lawrence 109
Princeton 109
Moscow 106
The Dalles 106
Wilmington 103
Ann Arbor 101
L’Aquila 94
São Paulo 84
Lauterbourg 80
New York 78
Ho Chi Minh City 69
Hangzhou 59
Nanchang 58
Woodbridge 54
Milan 53
Beijing 52
Hanoi 50
Hefei 43
Shenyang 42
Los Angeles 39
Verona 37
Hebei 31
Tianjin 31
Des Moines 30
Toronto 30
Mountain View 29
Brussels 28
Changsha 27
Jiaxing 25
Jinan 25
L'aquila 25
Kunming 24
Seattle 22
Helsinki 18
Frankfurt am Main 17
Montreal 17
Ningbo 17
Munich 16
Tokyo 15
Zhengzhou 15
Da Nang 14
Norwalk 14
Taipei 14
Shanghai 13
Düsseldorf 12
Phoenix 12
Warsaw 12
Atlanta 11
Brooklyn 11
Haiphong 11
Johannesburg 11
Lanzhou 11
Manchester 11
Poplar 11
San Francisco 11
London 10
Taizhou 10
Chennai 9
Denver 9
Turku 9
Boston 8
Orem 8
Rio de Janeiro 8
Guangzhou 7
Stockholm 7
Amsterdam 6
Auburn Hills 6
Chicago 6
Falkenstein 6
Perugia 6
Columbus 5
Fremont 5
Goiânia 5
Mexico City 5
Nuremberg 5
Philadelphia 5
Porto Alegre 5
Rome 5
Salvador 5
São José dos Campos 5
Ankara 4
Belo Horizonte 4
Biên Hòa 4
Bến Tre 4
Charlotte 4
Franca 4
Totale 8.173
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell chronic lymphoproliferative disorders 242
HSV-TK gene as a potential tool for generating a controlled graft-versus-host/graft-versus-leukemia effect 209
Activated T lymphocytes exert an anti-tumoral effect against autologous chronic lymphatic leukemia cells 189
HSV-TK transduced T-lymphocytes: in vitro and in vivo studies 180
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 171
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 170
Notch1 modulates MSC-mediated regulatory T cell induction 166
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 162
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 157
Constitutive phosphorilation of the active Notch1 intracellular domain in chronic lymphocytic leukemia with Notch1 mutation 156
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 155
The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. 152
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: adaptation to hypoxia or prevention from oxidative stress? 145
Adoptive immunotherapy with Treg and Tcon separates GvL from GvHD in HLA-haploidentical stem cell transplantation. 143
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 140
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 139
NOTCH signalling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 135
A revised Notch1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 131
HLA-haploidentical transplantation with regulatory and conventional T cell adoptive immunotherapy prevents acute leukemia relapse 129
Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation. 129
T lymphocytes transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparing four different infection protocols 128
T cell pathway deficiencies in Chronic Lymphocityc Leukemia: partial restoration with OKT3/IL-2 activation 128
Role of DNA-demethylating agent 5-azacitidine in maintenance of transgene expression in SCID mice. A study performed with a bicistronic retroviral vector 127
Notch1 PEST domain mutation is an adverse prognostic factor in B-CLL 126
B-chronic lymphocytic leukemia exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha 126
T regulatory cell separation for clinical application 125
"Designed" grafts for HLA-haploidentical stem cell transplantation 122
Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? 122
The iron chelator deferasirox affects redox signalling in hematopoietic stem/progenitor cells. 121
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 121
T-lymphocytes function after retroviral mediated thymidine kinase gene transfer and G418 selection 120
In vivo demethylation of a MoMULV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5-azacytidine 119
Transformation by Retroviral Vectors of Bone Marrow-Derived Mesenchymal Cells Induces Mitochondria-Dependent cAMP-Sensitive Reactive Oxygen Species Production 118
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma. 118
Beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocytes reaction 117
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and ehanced green fluorescence protein genes in primary T lymphocytes 117
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation 115
Adoptive immunotherapy with Tregs and Tcons rebuilds post transplant immunity and is associated with low TRM in HLA-haploidentical transplantation 115
The rs5743836 polimorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 114
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation 113
Melphalan alone versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for multiple myeloma 113
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 113
To breath or not to breath: the hematopoietic stem/progenitor dilemma 112
Effect of trichostatin A and 5'-azacytidine on transgene reactivation in U937 transduced cells 112
Immunoselection and clinical use of T regulatory cells in HLA haploidentical stem cell transplantation 111
Notch and NF-kB interplay in Chronic Lymphocytic Leukemia is independent of genetic lesion 107
G-CSF induced thrombocytopenia in a healthy donor 107
evidence of jak2 val617phe positive essential thrombocythemia with splancin thrombosis during estroprogestinic treatment 107
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis 107
5-azacytidine and prevention of proviral DNA hypermethylation: implication for gene therapy 107
Next gebneration in HLA-haploidentical HSCT. 107
“Suicide” gene transduction into U937 leukemic cell line 107
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 106
Naive and Memory T Regulatory Cells Respond to Mesenchymal Cells Regulation 106
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 105
Homing and kinetics of thymidine kinase transduced T lymphocytes in NOD/SCID mice 105
5-azacytidine prevents transgene methylation in vivo 104
CD34+ cells from AML with mutated NPM1 harbor cytoplasic muatated nucleophosmin and generate leukemia in immunocompromised mice 103
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone 103
Effects of G418 on thymidine kinase/neomycine resistance transduced T lymphocytes 103
Transduction of beta-galactosidase gene into U937 cell line: in vitro and in vivo evidence of stably expression of the transgene 102
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma. 101
Treating two concurrent B and T cell lymphoid neoplasms with alemtuzumab monotherapy 101
PET imaging of mesenchymal stem cells carrying the HSV-1 thymidine kinase reporter gene. Comaprison between adenoviral and retroviral infection 99
Adoptive immunotherapy with Tregs and Tcons promote a GvL effect in absence of GvHD in HLA-haploidentical transplantation. 99
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis. 97
Expression of thymidine kinase and LacZ genes in SCID mice by using a new retroviral vector. 97
Clonable T lymphocytes after thymidine kinase transduction and ganciclovir treatment 97
Immuno-magnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications 96
Homing and survival of thymidine kinase human T cells in NOD/SCID mice 96
Retroviral mediated gene transfer into T lymphocytes stimulated by either PHA/IL-2 or a mixed lymphocyte reaction 96
Adoptive immunotherapy with Tregs prevents GvHD and favours immune reconstitution after HLA haploidentical transplants for hematological malignancies 95
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 94
Graft engineering for allogenic haploidentical stem cell transplantation 93
Activated autologous T cells exert an anti B-cell Chronic Lymphatic Leukemia effect in vitro and in vivo 93
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 93
Adoptive immunotherapy with Tregs and Tcons ensures low TRM and a low incidence of post transplant leukaemia relapse after HLA haploidentical transplants for acute leukaemia. 93
Mesenchymal cells recruit and regulate T regulatory cells 92
Primary eyelid plasmacytoma 92
Activated autologous T lymphocytes exert an anti-tumoral effect against chronic lymphatic leukemia (CLL) cells 92
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 91
NeoR-based transduce T lymphocytes detected by real time quantitative polymerase chain reaction 91
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes 90
A microelectronic DNA chip detects the V617 JAK2 mutation in myeloproliferative disorders 89
Retroviral transfer of Herpes Simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 89
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and support immunological reconstitution after HSCT in NOD/SCID mice 89
Does 5-azacytidine increase transgene expression? Results of a preliminary in vivo study 89
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 88
Interleukin 7 engineered stromal cells: a new approach for hastening naive T cell recruitment 88
A Microelectronic DNA Chip Detects the V617F JAK-2 Allelic Ratio in Myeloproliferative Disorders 88
Interleukin7 engineered mesenchymal cells: in vitro effects on naive T cell population 87
Retroviral trasduction of the beta-galactosidase gene in natural killer and B lymphocytes: an analisys of the ability of this vector to infect lymphocyte subpopulations 87
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study. 86
Mesenchymal cells: a vehicle for gene therapy 85
MtDNA muattion associated with mitochondrial dysfunction in megacaryoblastic leukaemic cells 84
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 83
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 82
IL-7 transduced mesenchymal cells home to lymphoid organs and improve immunological reconstitution in NOD/SCID mice. 82
Interleukin 7 retroviral gene transfer in human stromal cells enhances th survival of naive T lymphocytes 82
Homing and survival of thymidine kinase transduced T lymphocytes into NOD/SCID mice. 81
Totale 11.406
Categoria #
all - tutte 48.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022628 0 84 138 55 22 0 16 40 32 26 50 165
2022/20231.916 147 102 45 187 213 216 0 128 791 10 44 33
2023/2024457 154 33 21 89 28 47 19 29 0 7 12 18
2024/20251.882 118 21 176 24 206 202 255 167 370 77 126 140
2025/20263.285 111 310 192 420 322 300 692 91 307 275 229 36
2026/2027530 68 462 0 0 0 0 0 0 0 0 0 0
Totale 12.064